arrow
R

Ruth Flümann

university of cologne and centre for integrated oncology aachen bonn cologne duesseldorf and excellence centre for medical mycology
H指数:7
被引数:235

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of an on-site vaccination campaign for patients with cancer

针对癌症患者的现场疫苗接种活动的有效性

2026-09-070
OA
Non-ICANS neurotoxicity after BCMA-directed CAR-T therapy: Clinical spectrum, outcomes, and a framework for neurology–oncology co-management

BCMA靶向CAR-T疗法后的非ICANS神经毒性:临床谱系、结局及神经科-肿瘤科协同管理模式框架

2026-06-150
OAAI
Lymphoma accelerates T cell and tissue aging

淋巴瘤加速T细胞和组织衰老

2025-08-210
OAAI
CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma

CSF1R⁺髓系-单核细胞驱动侵袭性B细胞淋巴瘤中CAR-T细胞的耐药性

2025-06-120
OAAI
Loss of IRF28P2 Drives an Actionable IL-1β/IL-1R Signaling Loop in DLBCL

IRF28P2的缺失驱动了DLBCL中一个可操作性的IL-1β/IL-1R信号环路

BLOOD
IF23.1
2024-11-050
PRE
An inducible Cd79b mutation confers ibrutinib sensitivity in mouse models of Myd88-driven diffuse large B-cell lymphoma
2024-02-282
OAAI
An anti-CD19/CTLA-4 switch improves efficacy and selectivity of CAR T cells targeting CD80/86-upregulated DLBCL
2024-02-012
OAAI
Mouse models of diffuse large B cell lymphoma

小鼠弥漫性大b细胞淋巴瘤模型

2023-12-061
OAAI
Distinct Genetically Determined Origins of Myd88/BCL2-Driven Aggressive Lymphoma Rationalize Targeted Therapeutic Intervention Strategies
2022-11-076
OAAI
An Aged/Autoimmune B-cell Program Defines the Early Transformation of Extranodal Lymphomas
2022-10-206
OA
An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
2021-01-1325
OA